Meyer HJ, Kretzschmar R. Kawa pyrone--a new kind of substance group of central muscle relaxants of the mephenesin type [translated from German].
Klin Wochenschr. 1966;44:902 - 903.
Klohs MW, Keller F, Williams RE, et al. A chemical and pharmacological investigation of
Piper methysticum
Forst.
J Med Pharm Chem. 1959;1:95 - 103.
Bruggemann VF, Meyer HJ. Studies on the analagesic efficacy of the kava constituents dihydrokavain (DHK) and dihydromethysticin (DHM) [in German; English abstract].
Arzneimittelforschung.
1963;13:407 - 409.
Meyer HJ. Pharmacology of the active compounds of the kava rhizome (
Piper methysticum
Forst) [translated from German].
Arch Int Pharmacodyn Ther. 1962;138:505 - 536.
Meyer HJ, May HU. Local anaesthetic properties of natural Kava pyrones [translated from German].
Klin Wochenschr.
1964;42:407.
Meyer HJ, Kretzschmar R. Kawa pyrone--a new kind of substance group of central muscle relaxants of the mephenesin type [translated from German].
Klin Wochenschr. 1966;44:902 - 903.
Singh YN. Effects of kava on neuromuscular transmission and muscle contractility.
JEthnopharmacol. 1983;7:267 - 276.
Davies LP, Drew CA, Duffield P, et al. Kava pyrones and resin: Studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain.
Pharmacol Toxicol. 1992;71:120 - 126.
Jussofie A, Schmiz A, Hiemke C. Kavapyrone enriched extract from
Piper methysticum
as modulator of the GABA binding site in different regions of rat brain.
Psychopharmacology (Berl). 1994;116:469 - 474.
Boonen G, Haberlein H. Influence of genuine kavapyrone enantiomers on the GABA
A
binding site.
Planta Med.
1998;64:504 - 506.
Emser W, Bartylla K. Improvement in sleep quality. Effect of kava extract WS 1490 on the sleep pattern in healthy subjects [in German, English abstract].
Neurol Psychiatr.
1991;5:636 - 642.
Holm E, Staedt U, Heep J, et al. The action profile of D,L-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals [in German].
Arzneimittelforschung.
1991;41:673 - 683.
Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - a randomized placebo-controlled 25-week outpatient trial.
Pharmacopsychiatry. 1997;30:1 - 5.
Kinzler E, Kromer J, Lehmann E. Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks [translated from German].
Arzneimittelforschung. 1991;41:584 - 588.
Warnecke G, Pfaender H, Gerster G, et al. Efficacy of an extract of kava root in patients with climacteric syndrome. A double blind study with a new mono-preparation [translated from German].
Z Phytother. 1990;11:81 - 86.
Warnecke G. Psychosomatic disorders in the female climacterium, clinical efficacy and tolerance of kava extract WS 1490 [translated from German].
Fortschr Med.
1991;109:119 - 122.
Malsch U, Klement S. Randomized placebo-controlled double-blind clinical trial of a special extract of kava roots (WS 1490) in patients with anxiety disorders of non-psychotic origin [abstract].
Eur Phytojournal
[serial online]. 2000; Issue 1. Available at:
http://www.escop.com/issue_1. Accessed May 10, 2001.
Woelk H, Kapoula O, Lehrl S, et al. The treatment of patients with anxiety. A double blind study: kava extract WS 1490 versus benzodiazepine [translated from German].
Z Allg Med. 1993;69:271 - 277.
Cropley M, Cave Z. Effect of kava and valerian on physiological responses to psychological stress assessed under laboratory conditions [abstract].
FACT.
2001;6:76.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:68.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:71.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:71.
Norton SA, Ruze P. Kava dermopathy.
J Am Acad Dermatol. 1994;31:89 - 97.
Schelosky L, Raffauf C, Jendroska K, et al. Kava and dopamine antagonism [letter].
J Neurol Neurosurg Psychiatry. 1995;58:639 - 640.
Escher M, Desmeules J, Giostra E, et al. Hepatitis associated with Kava, a herbal remedy for anxiety.
BMJ.
2001;322:139.
Strahl S, Ehret V, Dahm HH, et al. Necrotizing hepatitis after taking herbal remedies [translated from German].
Dtsch Med Wochenschr.
1998;123:1410 - 1414.
Munte TF, Heinze HJ, Matzke M, et al. Effects of oxazepam and an extract of kava roots (
Piper methysticum) on event-related potentials in a word recognition task.
Neuropsychobiology. 1993;27:46 - 53.
Heinze HJ, Munthe TF, Steitz J, et al. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials.
Pharmacopsychiatry. 1994;27:224 - 230.
Munte TF, Heinze HJ, Matzke M, et al. Effects of oxazepam and an extract of kava roots (
Piper methysticum) on event-related potentials in a word recognition task.
Neuropsychobiology. 1993;27:46 - 53.
Heinze HJ, Munthe TF, Steitz J, et al. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials.
Pharmacopsychiatry. 1994;27:224 - 230.
Schulz V, Hansel R, Tyler VE.
Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. 3rd ed. Berlin, Germany: Springer-Verlag; 1998:72.
Herberg KW. Effect of Kava-Special Extract WS 1490 combined with ethyl alcohol on safety-relevant performance parameters [in German, English abstract].
Blutalkohol. 1993;30:96 - 105.
Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam [letter].
Ann Intern Med. 1996;125:940 - 941.
Schelosky L, Raffauf C, Jendroska K, et al. Kava and dopamine antagonism [letter].
J Neurol Neurosurg Psychiatry. 1995;58:639 - 640.
Veh I, Chatterjee SS, Kiianmaa K, et al. Reduction of voluntary ethanol intake in alcohol-preferring AA-rats by kava extract. Presented at International Congress and 49th Meeting of the Society for Medicinal Plant Research; September 2 - 6, 2001; Erlangen, Germany.
Russmann S, Lauterburg BH, Helbling A. Kava hepatotoxicity [letter].
Ann Intern Med. 2001;135:68-69.
Kraft M, Spahn TW, Menzel J, et al. Fulminant liver failure after administration of the herbal antidepressant Kava-Kava [in German; English abstract].
Dtsch Med Wochenschr. 2001;126(36):970-972.
De Leo V, la Marca A, Morgante G, et al. Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety.
Maturitas.
2001;39:185 - 188.
Connor KM, Davidson JR. A placebo-controlled study of Kava kava in generalized anxiety disorder.
Int Clin Psychopharmacol. 2002;17:185-188.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.